Ketamine IV Classic Protocol : Five Years Follow up

Patients who suffer from MDD recieved ketamnie (2014-15) in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Major Depressive Disorder Chemically-Induced Disorders Depressive Disorder Depressive Disorder, Major Disease Attributes Drug Abuse Medications Mental Disorders Mood Disorders Pathologic Processes Pathological Conditions, Signs and Symptoms Recurrence Relapse Substance-Related Disorders

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

The Chaim Sheba Medical Center

Tel Litwinsky, 52621, Israel

About this study

Patients who suffer from Major Depressive disorder and are outpatients in our clinic and, received in the years (2014-15) ketamine in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient who participated in ketamine study 1126

Exclusion criteria

None

Treatment and study plan

non

Other

Follow up

Primary outcomes

Mood that will be evaluated using the MADRAS Montgomery-Asberg Depression Rating Scale".

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Sheba Medical Center

Other Gov

Registry information

Official study title

Ketamine IV Classic Protocol : Five Years Follow up Clinical Evaluation.

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Apr 1, 2021
Registry last updated: Apr 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed